Skip to main content
Advertisement
Advertisement
FTH
FTH logo
Faeth Therapeutics, Inc. Common Stock
22.05
USD
Sponsored
+2.13
+10.69%
Nov 06, 15:59 UTC -5
Closed
exchange

After-Market

24.95

+2.90
+13.15%

Faeth Therapeutics, Inc. Common Stock (FTH) Profile

Faeth Therapeutics, Inc. Common Stock Profile

About

Faeth Therapeutics Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The Company's lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. Faeth Therapeutics Inc., formerly known as Sensei Biotherapeutics Inc., is based in AUSTIN, Texas.

Info & Links

CEO

Christopher W. Gerry

Headquarters

1405 RESEARCH BLVD, SUITE 125
ROCKVILLE, MD 20850, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

193

Employees

23

Faeth Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

644.78M

Enterprise Value

630.60M

Enterprise Value/EBITDA(ttm)

-2.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.87

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-1012.17%

Return on Invested Capital(ttm)

76.72%

Return on Assets(ttm)

-175.69%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-215.95M

Net Income Available to Common(ttm)

-211.36M

Diluted EPS(ttm)

-138.82

Share Statistics

Beta (5Y Monthly)

-0.15

52-Week Change

--

S&P 500 52-Week Change

14.03%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

25.84M

Dividend Yield

0.00%

Float4

24.04M

% Held by Insiders

7.00%

% Held by Institutions

10.50%

Balance Sheet

Total Cash(mrq)

174.79M

Total Cash Per Share(mrq)

6.76

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.12%

Quick Ratio(mrq)

19.69%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.52

Free Cash Flow(ytd)

-39.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement